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Abstract: In this paper we show that controlling adhesion in highly flexible nanovectors can help in smartly delivering 
the drug. The high flexibility of the nanovector is used to smartly deliver the drug only at the target site by the new con-
cept of “adhesion induced nanovector implosion”; a liquid drop analogy is developed for the calculations. 
1. INTRODUCTION 
 Injectable drug-delivery nanovectors are used in 
nanomedicine for the cancer therapy, specifically for multi-
ple drug delivery, thermal ablation or imaging, see the recent 
reviews [1,2]. These vectors must be large enough to evade 
the body defences but sufficiently small to avoid blockages 
of even the capillaries, thus nanosized by definition. 
 Nanovectors can extravasate into the tumor through the 
enhanced permeation and retention (EPR) effect [3], roughly 
schematized in Fig. (1). The increased permeability of the 
blood vessels, i.e. the formation of new vessels from existing 
ones, leads to the permeation of nanovectors into the tumor; 
moreover, its dysfunctional lymphatic drainage retains them, 
allowing a localized drug delivery. Experiments with 
liposomes suggest that extravasation into tumors can take 
place if their diameter is <400nm [4] and becomes more effec-
tive for size <200nm [4-7]. Unfortunately some tumors do no  
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Fig. (1). A simplified scheme describing the concept of the 
nanovector therapeutics. 
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exhibit the EPR effect and this passive strategy could also 
induce a lack of control and thus multiple-drug resistance [2]. 
 To overcome these limitations nanovectors are function-
alized in order to actively bind to specific cells after ex-
travasation, through ligand-receptor interactions. To maxi-
mize specificity, a surface marker (receptor or antibody) 
should be overexpressed on target cells relative to normal 
ones. It is generally accepted that higher binding affinity 
increases targeting efficacy. However, for solid tumors, it 
could reduce penetration due to a binding-site barrier, where 
the nanovectors bind to its target so strongly that penetration 
into the tissue is prevented [8,9]. This suggests the impor-
tance of optimizing adhesion in nanovectors that is the aim 
of the present paper. Moreover, cancer cells often overex-
press the receptors for nutrition, thus growth factor or vita-
min interactions with cancer cells is an additional commonly 
used targeting strategy. 
 Finally, the nanovectors are activated and release their 
cytotoxic action when irradiated by external energy or by the 
environmental conditions, such as metabolic markers or the 
acidity levels that accompany inflammatory states, infections 
and neoplastic processes [1]. 
 Nanosized vectors include fusion proteins and immuno-
toxins/polymers (3-15nm), dendrimers (?5nm), polymer-
drug conjugates (6-15nm), miscelles (5-100nm, lipid based 
or polymeric), nanoparticles (10-40nm, gold, for photother-
mal ablation; 50-200nm, polymeric), liposomes (85-100nm), 
polymersomes (?100nm), immunoliposomes (100-150nm) 
and nanoshells (gold-silica, ?130nm, photothermal therapy) 
[2]. Absorbing nanoshells are suitable for hyperthermia-
based therapeutics, where they absorb radiation and heat up 
the surrounding cancer cells: above a thermal threshold irre-
versible damage selectively kills the cancer cells [2]. To 
achieve temporal release of two drugs, composite polymer 
core/lipid shell structures can be adopted [10]. 
 Polymers are the most commonly explored materials for 
nanovectors. Lipid-based nanovectors have attractive bio-
logical properties, such as biocompatibility, biodegradability 
and isolation of drugs from the surrounding environment. 
Between them the most famous are liposomes, single- or 
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multi-bilayered (within inner aqueous phases) spherical par-
ticles. They have shown preferential accumulation in tumor 
via EPR effect. However, too long-circulating liposomes 
may lead to extravasation of the drug into undesired sites. 
Long circulating half-life, soluble or colloidal behavior, high 
binding affinity, biocompatibility, easy functionalization, 
easy intracellular penetration, controlled pharmacokinetic 
and high drug protection are all characteristics simultane-
ously required for an optimal nanocarrier design. 
 However, controlling, under the body defences, both tar-
geting and drug delivery remains a complex task. Mechani-
cal studies can have a role in this, as suggested by the adhe-
sion of colloids on a cell surface in competition for mobile 
receptors [11] or in receptor-mediated endocytosis [12]. In 
this note we will introduce a new concept, of smart highly 
flexible (a property that could be crucial for smart drug de-
livering but still ignored in the literature) nanovectors, based 
on smart adhesion [13,14]. Adhesion between a nanovector 
and a cellular substrate is governed by the adhesion energy 
(van der Waals, electrostatic, steric, etc…) per unit area and, 
due to the tremendous surface to volume ratio of nano-
objects, becomes predominant at the nanoscale. Geckos and 
spiders take advantage of this [14], and nanovectors could 
make the same. During adhesion, the smart nanovector con-
siderably changes its shape in a controllable way and, in 
case, can implode due to buckling [15]. Thus the high flexi-
bility of the nanovector is used to release the drug only dur-
ing adhesion, by the new concept of “adhesion induced 
nanovector implosion”; a liquid drop analogy [13] is used for 
the calculations. Such a mechanism smartly delivers the drug 
in a controllable way, ideally aborting the tumor colonization 
[16]. 
 Obviously mechanical models in the field of life science 
have to be considered with caution, since much more com-
plex mechanisms could be prevailing. 
2. ADHESION OF LARGELY DEFORMED 
NANOVECTORS: A LIQUID DROP ANALOGY 
 The adhesion of liquid drops is a fascinating field, two 
hundred years old, see the noticeable review by Quèrè [17], 
and could present analogies with the adhesion of nanovectors 
[18], e.g. as recently observed for nanotubes [13]. For highly 
flexible nanovectors the inevitable presence of large dis-
placements, deformations and contacts renders the problem 
out of the domain of linear elasticity and in that of the elas-
tica theory of shells, for which only numerical integrations 
can be obtained, e.g. [15]. A liquid drop analogy could help 
in solving, even if in a approximated way, the problem: ac-
cordingly, we are going to extend the approach developed 
for cylindrical symmetry in [13] (applied to nanotubes) to 
the spherical symmetry (for nanovectors). 
 The adhesion of a (small, for which surface tension pre-
vails on gravity) liquid drop is fully described by the contact 
angle ? (a function of the liquid/solid/vapour surface ener-
gies) between drop and substrate, see Fig. (2a). Indicating 
with R0  the radius of the drop in air and with R the radius of 
curvature of the spherical cap describing the adhering drop, 
the radius of the contact area a can be calculated imposing 
the mass conservation. The adhesion of a nanovector of ra-
dius R0  can be similarly described by an equivalent contact 
angle ? (that we expect to be a function of the adhesion work 
and bending stiffness), the radius of curvature R  of the de-
formed non-contact cap and the contact radius a = R sin? ; 
thus the (maximum) height of the deformed nanovector is 
h = R 1? cos?( ) , see Fig. (2a). Assuming a porous mem-
brane of the nanovector, thus capable of exchanging mass 
and deliver drug, the surface inextensibility rather than the 
mass conservation has to be imposed, i.e. 
S = 2?Rh + ?a2 = 4?R02  (Fig. 2a). Accordingly we deduce: 
a
R0
=
2
1+ 2 1? cos?( ) sin2 ?            (1) 
 For small contacts ? ? ?  and 
a R0 ? 2 sin2 ? 1? cos?( ) . This asymptotic solution can 
be directly compared with the analytical result posed by elas-
ticity for a spherical shell with Young’s modulus E, Pois-
son’s ratio v, thickness t and contact surface energy ? , 
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Fig. (2). Nanovector (liquid drop) geometry, under large contact/deformation (a); squashed configuration (b). 
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which yields a R0 ? 2 12?R0? Et 2{ }  [19]; thus, we can 
define the contact angle for a nanoshell (e.g. liposome) ac-
cording to: 
sin2 ?
1? cos? =
R0
R0
* R0 ? 2R0*
sin2 ?
1? cos? = 2 R0 > 2R0
*
?
?
??
?
??
; R0
*
=
Et 2
? 12? 1??( ) ,          (2) 
in which the parameter 10 ???  takes into account the 
stiffening caused by the presence of a material (e.g. particles, 
liquid-like, etc.) inside the nanovector. For a porous mem-
brane ? ? 0  and the mass exchange has a vanishing energy 
cost. However, we may note that the membrane could be-
come non-permeable because of the adhesion of the plas-
matic proteins, unless proper wetting, electrostatic force, 
superficial charge are provided. 
 We have found that for a compact nanosphere eq. (2) 
would remain valid with R0
*
= 2R0 2ER0 3??( ){ }2 3 . 
 According to eq. (2), the contact will be hydrophobic or 
better nanovector-phobic (? > ? 2 , water/nanovector repel-
lent) or nanovector-philic (? < ? 2 ) for R0 < R0*  or 
R0 > R0
*
; or super-nanovector-phobic/philic (? ? ? , 0 ) for 
R0 ? 0  or R0 ? R0C( ) = 2R0* . For example, for a fullerene 
E ? 1TPa , t ? 0.34 nm, ? ? 0.2 J m2  (C-C van der Waals), 
R0
* ? 53nm  i.e. beyond a C1000000 molecule. A super-
nanovector-phobic behavior results in a high motility, 
whereas a super-nanovector-philic behaviour is ideal for 
maximize adhesion. Note that eq. (2) implies that the contact 
area becomes maximal ( 0=? ) for R0 ? R0C( ) = 2R0*  and 
thus not only for R0 ?? . This corresponds to a kind of 
implosion [15] (Fig. 2b). 
 Introducing eq. (2) into eq. (1) we find the following 
nonlinear law: 
a
R0
=
2
1+ 2 R0
* R0
R0 ? 2R0*
a
R0
= 2 R0 > 2R0
*
?
?
??
?
??
           (3) 
 For small contacts/deformations (? ? ? ) the prediction 
of eq. (3) is identical to the asymptotic solution reported in 
[19], whereas for large contacts/deformations (? ? 0 ) 
a R0 = 2 , as coherently imposed by the inextensible con-
dition (Fig. 2b). 
 The (maximum) height of the flattened nanovector and 
its radius of curvature can be geometrically derived as (Fig. 
2a): 
 
h
a
=
1? cos?
sin? , 
R
a
=
1
sin?            (4) 
 For ? ? 0 , h a? 0  and R a?? , whereas for 
? ? ? , h 2R0( )? 1  and R R0 ? 1 , confirming that the 
theory is self-consistent. 
 This model is more applicable to nanoshells (liposome 
like) than other kind of nanoparticles proposed on the market 
(lipid, polymeric and up to dendrimers), for which it proba-
bly needs new hypotheses. 
3. ADHESION INDUCED NANOVECTOR IMPLO-
SION 
 Designing a nanovector of size R0  with a proper elastic-
ity, or R0
*
 see eq. (2), allow us to control the volume varia-
tion of the nanovector induced by the adhesion energy. If the 
nanovector membrane is perfectly porous (? ? 0 ) an equiva-
lent volume ?V  of drug (we assume here an ideal 
nanopump, thus a unitary efficiency) will be smartly and 
suddenly delivered only at the target. The nanovector works 
here as a nanopump. Geometrically we find: 
?V = 4
3
?R03 ? ?3 2 + cos?( ) 1? cos?( )
2
R3           (5) 
 As a limit case for R0 = 2R0
*
, i.e. ? = 0 , ?V = 4?R03 3  
and the nanovector is fully imploded as a consequence of the 
adhesion with the target. Diffusive slow mechanisms will 
release the remaining amount of drug, still contained in the 
deformed nanovector after adhesion. We could thus control 
separately fast and slow drug deliveries, in order to optimize 
drug efficiency, by realizing a two-stage temporal nanovec-
tor. As a limit case, the adhesion induced implosion of the 
nanovector can be required. 
 The nanopumping mechanism will be activated in addi-
tion to different delivering strategies, e.g. endocytosis, and 
could be used for a global optimal design. For example en-
docytosis is predicted with a maximal efficiency for particles 
having size R ( 2 R = 1 Rp1 +1 Rp2  for non-spherical geome-
try, in which 1 Rp1,2  are the Gaussian principal curvatures) 
of ?20-30nm, with characteristic wrapping times of ?1-60s 
[12], even if other factors, in addition to the size, are ex-
pected to play a crucial role. An optimal colloid concentra-
tion also emerges [11]. We could imagine to delivery, by 
nanopumping, drug molecules with optimal size for endocy-
tosis (two-stage drug delivering process). Nanopumping is 
expected to be basically immediate and thus faster than en-
docytosis, but a competition between these two mechanisms 
could take place. 
4. CONCLUSIONS 
 In this paper we have shown that controlling adhesion in 
highly flexible nanovectors can help in smartly delivering 
the drug. The high flexibility of the nanovector is used to 
release the drug only during adhesion by nanopumping and, 
as a limit case, by the new concept of “adhesion induced 
nanovector implosion”; a liquid drop analogy have been used 
for the calculations, even if numerical exact solutions are 
under study. Fast (pumping) and slow (diffusion) drug deliv-
eries can thus be separately controlled. 
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